Literature DB >> 30196444

National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.

Ersi Voskaridou1, Antonis Kattamis2, Christina Fragodimitri3, Alexandra Kourakli4, Panagiota Chalkia5, Michael Diamantidis6, Efthymia Vlachaki7, Marouso Drosou8, Stilianos Lafioniatis9, Konstantinos Maragkos10, Fotini Petropoulou11, Eftihios Eftihiadis12, Marina Economou7, Evangelos Klironomos13, Freideriki Koutsouka14, Konstantina Nestora15, Ioanna Tzoumari16, Ourania Papageorgiou17, Artemis Basileiadi18, Ioannis Lafiatis19, Efthimia Dimitriadou20, Anastasia Kalpaka21, Chrysoula Kalkana22, Georgios Xanthopoulidis23, Ioannis Adamopoulos24, Panagiotis Kaiafas25, Aikaterini Mpitzioni26, Anastasia Goula27, Ioannis Kontonis28, Chrisoula Alepi29, Athanasios Anastasiadis30, Margarita Papadopoulou31, Polixeni Maili32, Dionisia Dionisopoulou33, Antigoni Tsirka34, Alexandros Makis35, Stavroula Kostaridou36, Marianna Politou37, Ioannis Papassotiriou38.   

Abstract

National registries constitute an invaluable source of information and contribute to the improvement of hemoglobinopathy management. Herein, we present the second updated report of the National Registry for Haemoglobinopathies in Greece (NRHG) and critically discuss the time trends in demographics, affected births, and causes of mortality. Thirty-eight Greek hemoglobinopathy units reported data from diagnosis to the last follow-up or death by retrospectively completing an electronic form. Four thousand thirty-two patients were eligible for inclusion; more than half of them had thalassaemia major. Compared to the previous report, a reduction in the total number of all hemoglobinopathies except for hemoglobinopathy "Η" was evident. The total number of affected births was also reduced; most of them were attributable to diagnostic errors and lack of awareness. Importantly, data on iron overload are reported for the first time; although most patients had low or moderate liver iron concentration (LIC) values, a non-negligible proportion of patients had high LIC. The burden due to heart iron overload was less prominent. Cardiac- and liver-related complications are the major causes of morbidity and mortality. From 2000 to 2015, a decrease in heart-related deaths along with an increase in liver-associated fatalities was observed. The Hellenic Prevention Program along with advances in chelation regimens and iron status monitoring have resulted in improved patient outcomes. The NRHG gives insight into the effectiveness of prevention programs, the therapeutic management of hemoglobinopathies and associated outcomes. NRHG may contribute to the formulation of a roadmap for hemoglobinopathies in Europe and promote the implementation of effective public health policies.

Entities:  

Keywords:  Greece; Hemoglobinopathy; Registry; Sickle cell disease; Thalassemia

Mesh:

Substances:

Year:  2018        PMID: 30196444     DOI: 10.1007/s00277-018-3493-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  7 in total

1.  Left atrial deformation indices in β-thalassemia major patients.

Authors:  Dimitrios Patsourakos; Constantina Aggeli; Konstantinos A Gatzoulis; Sophia Delicou; Yannis Dimitroglou; Katerina Xydaki; Christina Fragodimitri; Aristeidis Androulakis; Konstantinos Tsioufis
Journal:  Ann Hematol       Date:  2022-04-23       Impact factor: 3.673

2.  Twelve-lead and signal-averaged electrocardiographic parameters among beta-thalassemia major patients.

Authors:  Dimitrios Patsourakos; Konstantinos A Gatzoulis; Constantina Aggeli; Sophia Delicou; Yannis Dimitroglou; Katerina Xydaki; Konstantinos Toutouzas; Aristeidis Androulakis; Dimitrios Tousoulis
Journal:  J Arrhythm       Date:  2020-07-26

3.  Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry.

Authors:  Hishamshah Mohd Ibrahim; Zulaiha Muda; Ida Shahnaz Othman; Mohamed Najib Mohamed Unni; Kok Hoi Teh; Asohan Thevarajah; Kogilavani Gunasagaran; Gek Bee Ong; Seoh Leng Yeoh; Aisyah Muhammad Rivai; Che Hadibiah Che Mohd Razali; Nazzlin Dizana Din; Zarina Abdul Latiff; Rahman Jamal; Norsarwany Mohamad; Hany Mohd Ariffin; Hamidah Alias
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

Review 4.  Changing patterns in the epidemiology of β-thalassemia.

Authors:  Antonis Kattamis; Gian Luca Forni; Yesim Aydinok; Vip Viprakasit
Journal:  Eur J Haematol       Date:  2020-09-21       Impact factor: 2.997

Review 5.  Prevalence and specificity of red blood cell alloantibodies and autoantibodies in transfused Iranian β-thalassemia patients: A systematic review and meta-analysis.

Authors:  Hosein Rostamian; Ehsan Javandoost; Mozhdeh Mohammadian; Abbas Alipour
Journal:  Asian J Transfus Sci       Date:  2022-05-26

6.  Unmasking hypertension in children and adolescents with sickle/beta-thalassemia.

Authors:  Stella Stabouli; Christina Antza; Eleni Papadopoulou; Aikaterini Teli; Vasilios Kotsis; Marina Economou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

7.  The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients.

Authors:  Umberto Barbero; Matteo Ajassa; Carmen Maria Gaglioti; Antonio Piga; Giovanni Battista Ferrero; Filomena Longo
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.